Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

• Status: Completed
• Trial end date: 2011-05-01

Summary

We propose to use an inhaled allergen challenge model to explore the individual contributions of the components of a novel long-acting beta agonist/ inhaled corticosteroid combination product and its components on protection from allergic triggers in asthma

• Phase: Phase 2

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Xhance